Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding.

[1]  P. Lohman,et al.  The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques. , 1985, Carcinogenesis.

[2]  P. Lohman,et al.  Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. , 1985, Biochemistry.

[3]  W. Scovell,et al.  S1 nuclease sensitivity to cis- and trans-diamminedichloroplatinum(II) modified DNAS: influence of (G+C) content and nucleotide sequence. , 1984, Biochemical and biophysical research communications.

[4]  P. Lohman,et al.  A simple method for the inactivation of monofunctionally DNA-bound cis-diamminedichloroplatinum (II). , 1984, Journal of inorganic biochemistry.

[5]  S. Lippard,et al.  Use of antibodies to probe the stereochemistry of antitumor platinum drug binding to deoxyribonucleic acid , 1983 .

[6]  A. Eastman.  Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II). , 1983, Biochemistry.

[7]  J. Macquet,et al.  Physicochemical and Structural Studies of the In Vitro Interactions between Platinum(II) Compounds and DNA , 1983 .

[8]  S. Lippard.  New chemistry of an old molecule: cis-[Pt(NH3)2Cl2]. , 1982, Science.

[9]  M. Rajewsky,et al.  Development and possible use of immunological techniques to detect individual exposure to carcinogens: International Agency for Research on Cancer/International Programme on Chemical Safety Working Group Report. , 1982, Cancer research.

[10]  S. Lippard,et al.  Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Lohman,et al.  Detection and quantification of adducts formed upon interaction of diamminedichloroplatinum (II) with DNA, by anion-exchange chromatography after enzymatic degradation. , 1982, Nucleic acids research.

[12]  W. Scovell,et al.  Cis-diamminedichloroplatinum(II) modified DNA stimulates far greater levels of S1 nuclease sensitive regions than does the modification produced by the trans- isomer. , 1982, Biochemical and biophysical research communications.

[13]  W. Scovell,et al.  Cis- and trans-diamminedichloroplatinum(II) binding products different tertiary structural changes on SV40 DNA. , 1982, Biochemical and biophysical research communications.

[14]  P. van de Putte,et al.  Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II). , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Hartmann,et al.  Immunochemical studies of DNA modified by cis-dichlorodiammineplatinum(II) in vivo and in vitro. , 1981, Cancer research.

[16]  C. Parker,et al.  The preparation of nucleotide-protein conjugates: carbodiimides as coupling agents. , 1966, Journal of immunology.

[17]  A. Thomson,et al.  The mechanism of action of antitumor platinum compounds. , 1979, Progress in nucleic acid research and molecular biology.